GfK HealthCare Hires Three

In London, GfK Healthcare has appointed Dr Lolita Banerji as Associate Director in the International client team, while Julian Shepelev and Tega Gbenedio join as Research Manager and Research Executive in the Market Access team.

Banerji was most recently at clinical trial company Parexel International, where she worked as Feasibility Manager and headed a team based in Europe.

GfK Healthcare MD Sandra McAuliffe commented: 'Dr Banerji is a perfect match for us, bringing with her first-rate experience in performing both primary and secondary market research. Her detailed knowledge of the Oncology area and familiarity with EU and US regulatory submission and timelines will prove an invaluable asset in our International team.'

Shepelev was previously a Research Fellow with the London School of Hygiene and Tropical Medicine where he was involved in projects including health policy and decision making, health and human rights, drug policy, and the economic impact of mental health diseases.

Gbenedio joins from Phlexglobal, and worked previously at IMS Health where he sourced and processed data for therapy forecasters, R&D focus and ad hoc client requests.

GfK HealthCare is part of the GfK Group and is online at www.gfknop.com/healthcare. Last September, former Novartis Global Head of Consumer Insights McAuliffe became MD (www.mrweb.com/drno/news7301.htm ).

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.